DUBLIN, Mar 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Hospital Acquired Infection (HAI) Control Markets" report to their offering.

Hospital Acquired Infection (HAI) Control Markets provides a revenue analysis for the prevention, testing, and treatment of infections in the healthcare surroundings, including the world revenues for 2010-2021 for hospital infection control, for hospital infection treatment, and for hospital infection prevention equipment and consumables (sterilization/disinfection).

Sales information is also provided for the different market segments by primary geographic region (United States, Europe, rest of world) and leading manufacturers' shares.

Merck, Pfizer, GlaxoSmithKline, and Bayer are among the key companies in HAI control markets are among those manufacturers featured in the report's competitor analysis.

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY
OVERVIEW
THE NOSOCOMIAL INFECTION
MARKET SCOPE
RESEARCH METHODOLOGY
INDUSTRY CHALLENGES
TOTAL SIZE AND GROWTH OF THE MARKET
ISSUES AND TRENDS AFFECTING MARKET

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
OVERVIEW
Introduction to Pathogens
Classification of Antibacterial Organisms
COMMON HOSPITAL (NOSOCOMIAL) INFECTIONS
DESCRIPTION OF INFECTIONS
Acinetobacter Baumannii
Clostridium Difficile
Gastroenteritis
Hospital-Acquired Pneumonia (HAP)
Pseudomonas Aeruginosa
Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus
Stenotrophomonas Maltophilia
Tuberculosis
Urinary Tract Infections
Vancomycin-Resistant Enterococcus
Ventilator-Associated Pneumonia (VAP)
Patient Risk Factors
General Populations at Risk for Infection
Hospital Acquired Infection (HAI) Control Markets
WORLD DEMOGRAPHICS
Assessing the Problem: Nosocomial Infection Statistics
Hospital Length of Stay
U.S. GOVERNMENT'S NATIONAL PLAN TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
STEERING COMMITTEE
EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES
AFFORDABLE CARE ACT (ACA) FUNDING
EMERGING INFECTIONS PROGRAM
THE DEPARTMENT OF HEALTH AND HUMAN SERVICES: 2017 BUDGET HIGHLIGHTS
NATIONAL HEALTHCARE SAFETY NETWORK
HEALTHCARE INFECTION SURVEILLANCE PROCESS
PHARMACEUTICAL MANUFACTURER AND MARKETER TRENDS
Trends in Partnerships and Alliances
Developers Trends

CHAPTER THREE: INFECTION PREVENTION
OVERVIEW
MARKET OVERVIEW
Healthcare Infection Prevention Market by Geographical Region
Methods of Transmission
HIGH-RISK FACILITIES OR DEPARTMENTS
Acute Care Hospitals
Long-term Care Facilities
Outpatient Settings
Technology Overview
Sterilization vs. Disinfection
EQUIPMENT AND SOLUTIONS
HEAT/STEAM STERILIZATION
Product Examples
CHEMICAL AND GAS STERILIZATION
Disinfecting Agents and Medical Device Components
Sterilants
Product Examples
Mid-Level Disinfectants
RADIATION STERILIZATION
Product Examples
COMPETITIVE ANALYSIS

CHAPTER FOUR: INFECTION TESTING
OVERVIEW
TOTAL MARKET SIZE AND FORECAST
Healthcare Infection Testing Market by Geographical Region
TESTING FOR NOSOCOMIAL INFECTIONS
Drug-Resistance/Susceptibility Testing
Genotypic Methods
DNA Sequencing
Solid-phase Hybridization Techniques
Hospital Acquired Infection (HAI) Control Markets
Microarrays
Real-time Polymerase Chain Reaction Techniques
Phenotypic Methods
Phage-based Assays
Colorimetric Methods
The Nitrate Reductase Assay
Chromogenic Testing
SPECIFIC SERIOUS HEALTHCARE INFECTION TESTING
Acinetobacter Baumannii
Carbapenem-resistant Enterobacteriaceae
Clostridium Difficile
Product Examples
Hospital-Acquired Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus
Ventilator-Associated Pneumonia
DEVELOPMENTS
COMPETITIVE ANALYSIS

CHAPTER FIVE: INFECTION TREATMENT
OVERVIEW
TOTAL MARKET SIZE AND FORECAST
Healthcare Infection Treatment Market by Geographical Region
PRINCIPLES OF ANTI-BACTERIAL THERAPY
Infecting Organism
Antibiotic Sensitivity Testing
Site of Infection
Host Defenses and Organ Function
Antibiotic Pharmacokinetics
Monitoring Therapy
CLASSIFICATIONS OF ANTIBACTERIAL PRODUCTS
Aminoglycosides
Carbapenems
Cephalosporins
Glycopeptides
Macrolides
Penicillins
Quinolones
Sulfonamides
Tetracyclines
MARKET SIZE AND SALES DISTRIBUTION BY ANTIBIOTIC CLASS
INFECTIONS AND DRUG RESISTANCE
Easing Approvals of Antibiotics
QUALIFIED INFECTIOUS DISEASE PROGRAM DESIGNATIONS
Causes of Drug Resistance
Drug Resistance in Select Populations
Treatment Guidelines
NEW DEVELOPMENTS
New Developments in Biotherapies for Infection Treatment
COMPETITIVE ANALYSIS
Leading Products

CHAPTER SIX: MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL
MARKET CONSIDERATIONS
MARKET OVERVIEW
Healthcare-Acquired Infection Distribution by Setting
Healthcare Infection Control Market by Geographical Region
Developed and Emerging Market Analysis

CHAPTER SEVEN: COMPANY PROFILES
INTRODUCTION
3M
Abbott Laboratories
Abbvie
Advanced Sterilization Products
Alere
Astrazeneca
Bayer
Becton, Dickinson And Company
Belimed
Biomérieux S.A.
Cantel Medical Corp.
Danaher Corporation
Getinge Group
Glaxosmithkline Plc
Merck & Co.
Pfizer, Inc.
Roche
Sakura Seiki Co., Ltd.
Steris Plc
Tso3, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/dh9bs6/hospital_acquired

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets